Purpose: The objective of this study was to evaluate the association between depression and change in coronary heart disease (CHD) risk status by an analysis of examination data in the general Korean population.
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Introduction
Cardiovascular disease (CVD) and depression are currently the two most common causes of disability in high-income countries and are expected to become so for countries of all income levels by 2030. 1 The key health system and economic indicators related to CVD and depression reveal rising medical costs, increased health service utilization, and lost productivity. 2 There is no argument that depression is a risk marker for an increased incidence of new coronary heart disease (CHD). 3, 4 Conversely, patients with CHD are more likely to suffer from depression than the general population. 5 Mild depression was identified in up to two-thirds of patients after acute myocardial infarction (MI), 6 with major depression observed in 31.1% of MI patients. 7 Furthermore, for depression to be causally related to the CHD incidence and prognosis, numerous clinical studies have demonstrated that depression is a "risk factor" rather than just submit your manuscript | www.dovepress.com
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Jang et al a "risk marker." [8] [9] [10] [11] However, despite ongoing efforts to improve the identification and treatment of depression, the association is still not explicable by known covariates. 12 However, this relationship has not been investigated by monitoring the CHD risk scores of individuals. A large proportion of patients who suffer sudden cardiac death or nonfatal MI do not experience prior symptoms: indeed, as many as 50% of MIs occur in persons without a known history of symptomatic CHD. Therefore, it is important to identify individuals at risk of coronary events before they develop clinical symptoms. Regularly estimated CHD risk scores using biochemical data can influence clinical decisions about the type and intensity of therapies. Furthermore, a study of the main factors associated with CHD risk and their relationship to depression could solve the difficulty in identifying patients who ultimately suffer cardiovascular events.
In this study, we investigated whether depression can influence the movement of a low-risk CHD score population to an intermediate-or high-risk CHD score population using a population-based cohort design.
Materials and methods study population
This population-based longitudinal study was part of the community-based Korean Genome Epidemiology Study (KoGES)-Ansan. 13 This investigation was initiated in 2001 with the support of the Korean National Institute of Health. Our data accessed from the KoGES were freely available if researchers submitted an appropriate Institutional Review Board clearance to the Korea Centers for Disease Control and Prevention. The study protocol was approved by the Institutional Review Board of Seoul National University (IRB No E-1606-003-001). A baseline examination was performed on enrolled participants in 2001-2002, and biennial follow-up examinations were subsequently conducted. This study focused on 3,540 participants (age range 40-79 years) who had answered a questionnaire about their depression status in 2005. This retrospective cohort study included participants enrolled from 2005 to 2006 and followed until the fourth follow-up (8 years). Two thousand three hundred and eighty-three cohort members aged 40-79 years were analyzed after exclusion of 1,157 subjects who were lost to follow-up (n=840); had missing data (n=201); had a history of CHD (n=87), cardiac revascularization (n=8), stroke (n=10), or chronic heart failure (n=2); or had a previous diagnosis of depression or had been medicated for depression (n=9). Finally, we selected participants whose Framingham CHD risk score was in the low-risk score group at baseline (n=1,582; Figure 1 ), and we analyzed whether these participants moved to the intermediate or high CHD risk score group after the fourth follow-up. 
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Measurements Demographic variables
Data in this study were from the KoGES. For assessment of cardiovascular risk, resting blood pressure (BP) was measured twice by trained technicians, and body mass index (BMI; kg/m 2 ) was calculated. Serum high-density lipoprotein cholesterol (HDL), total cholesterol, and hemoglobin A1c (HbA1c) were determined from blood samples. Demographic, medical history (including brief medication information), health conditions, and family history of disease information were collected using interviewer-administered questionnaires.
Additionally, information about smoking (pack-year), alcohol (g/d), education status, annual income, and menopause status were collected. All examinations were administered by health professionals trained to follow standardized protocols. 14 
assessment of depression
The Beck depression inventory (BDI), which has a 21-item self-report inventory, was used to assess the severity of depressive symptoms. The BDI is a well-validated measure of depressive symptoms and has high sensitivity and specificity for diagnosis of depression. 15, 16 Self-evaluative statements in the questionnaires were graded to measure the severity of depressive symptoms. Total scores on the BDI can range from 0 to 63, with higher scores reflecting greater levels of depressive symptoms. The presence of depression was defined by a BDI score $10.
15
Calculation of ChD risk score
Estimated 10-year CHD risk score was calculated using Framingham risk scores. 17 This calculation was based on the study of cardiovascular risk profile detailed in the online Framingham Heart Study. The following variables were used: gender, age, systolic blood pressure (SBP), HDL, total cholesterol, hypertension treatment (yes or no), and smoking (yes or no). Individuals were allocated points from each category, and then their 10-year Framingham CHD scores were calculated from their total points. We defined the intermediate or high CHD risk score cut-off point as a Framingham CHD score $10. ) for continuous variables and proportions for categorical variables. Comparisons of demographic variables were performed using Student t-tests for continuous variables and χ 2 or Fisher's exact tests for categorical variables. Multivariate logistic regression analyses to determine whether the low CHD risk score group of subjects changed to the intermediate or high CHD risk score group according to depression status was performed by analysis of the covariates: age, SBP, HbA1c, HDL, total cholesterol, smoking, BMI, alcohol, education, and annual income. Covariates for the multivariate model were selected on the basis of univariate correlation analysis and clinical relevance. In terms of covariates used in our multivariate logistic regression analysis, our outcome was whether participants moved to the intermediate or high CHD risk score group, which is not a Framingham CHD risk score itself. Furthermore, the risk of being in the intermediate-or high-score group after 8 years could be affected by the baseline Framingham risk score. Therefore, we adjusted for individuals' risk factors in the baseline period that were used in calculating the baseline Framingham CHD risk score. Variables were reduced using backward elimination at α=0. 15. 20,21 Data were analyzed using the IBM SPSS statistical package (version 23.0; IBM Corp., Armonk, NY, USA). Probability values P,0.05 (two-sided) were considered statistically significant.
Results
Demographic data
Data from 1,582 subjects aged 43-73 years, including 420 men and 1,162 women, were analyzed in this study. Demographic and clinical characteristics of the study participants according to the presence of depression are listed in Table 1 . The mean age of all participants was 51.1±6.67 years. The mean ages of men with (BDI $10) and without (BDI ,10) depression were 48.5 and 48.0 years, respectively, and were not significantly different (P=0.249); however, the mean ages of women with and without depression were significantly different at 53.4 and 51.6 years, respectively (P,0.001). The overall mean BDI scores were 7.81±6.68 (range 0-42), while scores for men with and without depression were 14.2 and 3.6, respectively, and the corresponding scores for women were 15.8 and 4.4, respectively. The mean Framingham CHD risk scores in men were 5.3% and 5.0% in those with and without depression, respectively (P=0.215), and were higher than those in women (1.7% and 1.5% for those with and without depression, respectively; P=0.014). The prevalence of menopause was higher in women with depression (60.6%) than in women without depression (46.5%; P,0.001).
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Changes in Framingham ChD risk scores
Changes in Framingham CHD risk score between baseline and 8-year follow-up according to age and gender of cohort participants are shown in Figure 2 . At baseline, the number of participants with Framingham CHD risk scores ,10% were lower among men (n=420) than women (n=1,162) for all age groups. The number of men older than 55 years was lower than that of men less than 55 years old at baseline because many were excluded as part of the study criteria (low Framingham risk score group). In contrast, women had relatively low risk score status even when they were older than 70 years. After the 8-year follow-up period, CHD risk scores became higher in men, regardless of their age; however, in women, CHD risk score status began to alter when they reached ages above 55 years.
association between depression and cardiac risk score 
Discussion
To the best of our knowledge, this is the first report to demonstrate that depression is associated with a risk of moving from a low-risk CHD group to an intermediate-or a high-risk CHD group. The CHD risk score is reliable and has been used in numerous observational studies. 22 The variables for CHD risk prediction can be obtained using blood samples and questionnaire information. Additionally, BDI scores 
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Depression and coronary heart disease risk score have been used in many studies and have been shown to have good test-retest reliability and validity. [23] [24] [25] By analyzing and adjusting for each risk factor, we could identify to what extent each risk factor was correlated with the BDI scores. Additionally, through the analysis of these robust data, we assessed the overall association between CHD risk score and depression.
The prevalence of depression in Korea ranges from 4.3% to 9.1%, while that of depressive symptoms is between 9.1% and 33.0%. 26 In our study population, depression (BDI $10) occurred in 23.6% (99 of 420) and 35.4% (411 of 1,162) of the men and women with low CHD risk scores, respectively. Consistent with a previous report, 27 we found that women had inferior depression scores to men. In general, the CHD incidence rate in men is higher than that in women. 28 In agreement with this, our results indicate that the baseline CHD risk scores of men (5.1%±0.1%) were higher than those of women (1.6%±0.4%). In this study, women older than 55 years showed a change in the CHD risk score status. In the Adult Treatment Panel III, researchers also reported an age of 55 years or older as a positive risk factor for their intermediate-or high-risk score status in women. 29 In our study, the incident rate for a change in the CHD risk score status was 62.4% (262 of 420) in men and 3.4% (40 of 1,162) in women after the 8-year follow-up period.
Depression increased the likelihood of women, but not men, being in an either the intermediate or high CHD risk score group after the follow-up period. In terms of covariates used in our multivariate logistic regression analysis, our outcome was whether participants moved to the intermediate or high CHD risk score group, which is not a Framingham CHD risk score itself. Furthermore, the risk of being in the intermediate-or high-score group after 8 years could be affected by the baseline Framingham risk score. 
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Jang et al Therefore, we adjusted for individuals' risk factors in the baseline period that were used in calculating the baseline Framingham CHD risk score. However, because of the large effect of age on the Framingham CHD risk score, 30 ,31 the effect of depression may have been downsized. One study did an age-grouped analysis to solve this problem. 32 Therefore, we did a subgroup analysis in men older than 45 years and in women older than 55 years. The age cutoff was determined in the Adult Treatment Panel III final report. 29 The result shows that the BDI category still has a significant value in terms of belonging to the intermediate or high CHD risk score group after adjusting for age, SBP, HbA1c, and smoking in women (adjusted OR, 2.11; 95% CI, 1.06-4.19) but not in men (adjusted OR, 1.26; 95% CI, 0.73-2.19).
There have been several reports regarding the differences in CHD outcomes between men and women with CVD and comorbid depression. Women were reported to be susceptible to CHD when depressed; 10 however, the Danish Glostrup study found that gender did not affect the association of increased depression with increased risk of MI and mortality, despite the prevalence of depression among women being higher than that among men. 8, 33 Another study showed that depressed women did not have a significant increase in risk, while depressed men did for CHD mortality. 9 This difference could be due to some unknown physiological disorders that may occur due to depression. 27 These disorders can cause autonomic dysfunction, hypercortisolemia, elevated catecholamines and inflammatory markers, endothelial dysfunction, and platelet activation. 34 They are also related to the hyperactivity of the hypothalamic-pituitary-adrenal axis and defective serotonin signaling, which result in the dysfunction of the amygdala. 
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Generally, the effects of depression can be revealed by examining the behavior of individuals as well as by their physiological measures. In our population, depressed men were more likely to have a higher SBP and smoking than that of the nondepressed men at baseline. Men have been reported to be more likely than women to show changes in traditional physiological measures, such as a high BP, and depression in men has a key role in cigarette smoking. 35, 36 After the follow-up period, SBP and smoking were also associated with the change in CHD risk score status, regardless of gender, similar to a number of previous reports. [35] [36] [37] Menopause is an important physiological factor because of its hormonal effects in women; however, menopause was not significantly associated with belonging to the intermediate or high CHD risk score group after a multivariate analysis. We did an additional subgroup analysis of postmenopausal women, and depression was significantly related to being in the intermediate or high CHD risk score group (adjusted OR, 1.69; 95% CI, 1.17-2.23) after adjusting for age, SBP, HDL, and smoking. In another study of postmenopausal women, depression was also significantly associated with an increased risk of cardiovascular death and all-cause mortality. 38 Education and annual income were different between the low and high BDI groups; however, they were not associated with the change in CHD risk score status. Another study of depressed people also found no relationship between socioeconomic status and CHD outcomes. 39 This study has several limitations. First, we controlled for baseline risk factor status and lifestyle variables that affected the CHD risk score in our analyses; additionally, we had no data on adherence to medication. It is possible that participants who reported depressive symptoms were less adherent to their medication, which would put them at a greater risk of CHD events. Further study is required regarding how antidepressants and medication compliance affect the change in CHD risk score status. Additionally, there was a study showing that the Framingham risk function overestimates the risk of CHD in the Korean population, in which the CHD incidence is low; 30 however, this method of scoring has been the basis of CHD risk assessment in numerous clinical settings including Korea. 18, 32 The strengths of this study include the use of cohort data with a large sample size as well as a relatively long follow-up period. We were also able to analyze data separately for women and men. Of particular interest, the results of this study indicate that although other variables are already used to estimate the CHD risk score, depression also affects the likelihood of developing an intermediate or high risk of CHD, especially among women, indicating that it is a significant relevant risk factor. Another strength of this study was our ability to control for numerous cardiac risk factors and demographic variables.
Conclusion
Our results suggest that clinical depression can lead to a change in CHD risk score status in Korean women. These findings may be useful for determining appropriate disease management or therapeutic lifestyle changes of depressed populations. The assessment, treatment, and monitoring each risk factors will have an important effect on clinical care, research investigation, and treatment guidelines. In addition, research into whether changes to intermediate or high CHD risk score status are reversible through pharmacologic or psychotherapeutic interventions is required.
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